Skip to main content
BASKHANBIOPharma Inc. logo

BASKHANBIOPharma Inc. — Investor Relations & Filings

Ticker · 354390 ISIN · KR7354390007 KO Manufacturing
Open in API
Filings indexed 71 across all filing types
Latest filing 2026-05-12 Investor Presentation
Country KR South Korea
Listing KO 354390

About BASKHANBIOPharma Inc.

http://www.baskhanbio.com/

BASKHANBIOPharma Inc. is a pharmaceutical company focused on pain management and improving patient quality of life. The company engages in the manufacture, sale, and distribution of a diverse product portfolio. Its core offerings include prescription drugs, over-the-counter (OTC) medicines, and medical devices, with a particular emphasis on products used before, during, and after surgical procedures. In addition to its primary pharmaceutical and medical device operations, the company's business areas also encompass health functional foods and cosmetics.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 72% confidence The document is an official disclosure announcing the scheduling and details of a corporate investor relations presentation (기업설명회, IR). It provides date, time, participants, agenda, and location for the investor presentation event. This is not an earnings release or interim report, nor a proxy or dividend notice, but specifically an Investor Presentation announcement. Therefore, it fits the “Investor Presentation” category.
2026-05-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 87% confidence The document is a detailed ‘주식등의 대량보유상황보고서’ (Large Shareholding Report) under Korean capital markets law, disclosing changes in significant share ownership, holdings by the controlling shareholder and related parties, and threshold movements. This matches the definition of a Major Shareholding Notification (MRQ).
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 82% confidence The document is a report titled “정기주주총회 결과” (Regular Shareholders’ Meeting Results) detailing agenda items, voting resolutions, vote percentages, and decisions made at the annual general meeting. It is not the meeting notice or presentation materials, but the official declaration of voting results, matching the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-26 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Baskan Bio Pharm' (바스칸바이오제약) for the fiscal year ending December 31, 2025. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an earnings release or a simple announcement. FY 2025
2026-03-18 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) which provides the audit opinion, financial highlights, and auditor information for the fiscal year ending 2025. It also includes a correction notice regarding the consolidated financial statement submission status. Since this is a standalone report of audit results and financial data rather than a full annual report or a mere announcement of a report's availability, it falls under the Audit Report category. FY 2025
2026-03-12 Korean
감사보고서제출
Audit Report / Information Classification · 97% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) by Baskan Bio Pharm. It provides the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, revenue, profit), and details about the external auditor (Samduk Accounting Corp). While it contains financial data, it is a summary disclosure of the audit results rather than the full annual report or a standalone audit report document. According to the filing definitions, this is a report publication announcement regarding the audit results. FY 2025
2026-03-12 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.